Related Experiment Video

Updated: Jul 3, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Decreasing incidence of critical limb ischemia after intra-aortic balloon pump counterpulsation

Petra Dick1, Wolfgang Mlekusch, Georg Delle-Karth

  • 1Department of Angiology, Medical University of Vienna, Vienna, Austria.

Angiology
|July 5, 2008
PubMed

Insights

Critical limb ischemia (CLI) occurred in 10% of patients receiving intra-aortic balloon pump (IABP) support. While CLI is not a primary concern due to high mortality, IABP duration predicts its incidence.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Critical Care Medicine

Background:

  • Intra-aortic balloon pump (IABP) support is crucial for patients with cardiogenic shock post-myocardial infarction.
  • Critical limb ischemia (CLI) is a potential complication following IABP implantation.
  • Understanding CLI incidence and risk factors in IABP patients is essential for optimizing care.

Purpose of the Study:

  • To investigate the incidence of CLI in patients requiring IABP support.
  • To identify risk factors associated with CLI development in this cohort.
  • To determine the long-term outcomes of patients who develop CLI after IABP support.

Main Methods:

  • Retrospective analysis of 187 patients who received IABP support over a 6-year period.
  • Assessment of CLI incidence and associated risk factors.
  • Evaluation of long-term patient outcomes (median 5 years post-discharge).

Main Results:

  • CLI occurred in 10% of patients post-IABP implantation.
  • The incidence of CLI has significantly decreased in recent years.
  • Duration of IABP support was identified as a significant predictor for CLI.
  • Cardiogenic shock post-acute myocardial infarction was the primary indication for IABP.

Conclusions:

  • Despite a 10% incidence, CLI is not a primary concern in IABP patients due to the high overall mortality.
  • The decreasing incidence of CLI suggests improvements in patient management or IABP technology.
  • Prolonged IABP support duration is a key modifiable risk factor for CLI development.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...